{"id":3572,"date":"2020-10-26T20:05:24","date_gmt":"2020-10-26T20:05:24","guid":{"rendered":"https:\/\/gpsites.co\/health\/?page_id=3572"},"modified":"2023-01-07T15:44:19","modified_gmt":"2023-01-07T15:44:19","slug":"home","status":"publish","type":"page","link":"https:\/\/synthonicsinc.com\/","title":{"rendered":"Home"},"content":{"rendered":"
\n
\n
\n\n

<\/path><\/svg><\/span>SYnthonics Inc<\/span><\/p>\n\n\n\n

We harnesses the power of Metal Coordinated Pharmaceuticals (MCPs) to save lives.<\/h2>\n\n\n
\n\nDiscover why MCPs are the Future.<\/a>\n\n<\/div>\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n
\n
\n
\n\n

<\/path><\/path><\/svg><\/span>2200 Kraft Drive, Suite 2225
Blacksburg, VA, <\/span><\/p>\n\n<\/div><\/div><\/div>\n\n

\n\n

<\/path><\/path><\/svg><\/span>540.443.3645
info@synthonicsinc.com<\/span><\/p>\n\n<\/div><\/div><\/div>\n\n

\n\n

<\/path><\/path><\/svg><\/span>All inquires will be
responded to within one business day.<\/span><\/p>\n\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n

\n
\n
\n\n

<\/path><\/svg><\/span>Welcome<\/span><\/p>\n\n\n\n

Synthonics Inc. is the global leader in Metal Coordination Pharmaceuticals, with 4 active US Patents and dozens more pending. <\/h2>\n\n\n\n

Metals have been considered for millennia to have medicinal values. With the advent of modern medicine, many metal-based drugs have proven to be highly effective in the clinic. Many different metal ions have shown activity against a range of diseases. The unique electronic structure of transition metals offers great versatility, not always seen in organic drugs, in terms of the ability to tune the properties of a given molecule (McQuitty<\/a>).<\/p>\n\n\n\n

In September of 2010, the U.S. Patent and Trademark Office issued the first patent in Synthonics\u2019 portfolio. This composition of matter patent, which covers a complex of zinc with triiodothyronine (T3), establishes the patentability of novel molecules created by chelating a metal to a known drug. Synthonics has since definitively demonstrated that Metal Coordination Pharmaceuticals (MCP) can significantly improve a drug\u2019s absorption. The portfolio currently hosts 4 US Patents for MCP technologies with dozens more pending. <\/p>\n\n\n\n

<\/p>\n\n<\/div><\/div><\/div>\n\n

\n\n
\"\"<\/figure>\n\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n
\n\n

<\/path><\/svg><\/span>Benefits OF MCP <\/span><\/h3>\n\n\n
\n
\n\n

<\/path><\/path><\/path><\/path><\/path><\/path><\/svg><\/span>Higher Efficacy<\/span><\/h4>\n\n\n\n

MCP improves efficacy of IV delivered drugs. <\/p>\n\n<\/div><\/div><\/div>\n\n

\n\n

<\/path><\/path><\/path><\/path><\/svg><\/span>Faster Absorption<\/span><\/h4>\n\n\n\n

MCP speeds the onset of action of Over The Counter (OTC) products.<\/p>\n\n<\/div><\/div><\/div>\n\n

\n\n

<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg><\/span>Less Variability<\/span><\/h4>\n\n\n\n

MCP reduces the variability of absorption of relatively insoluble drugs, such as furosemide.<\/p>\n\n<\/div><\/div><\/div>\n<\/div>\n\n

\n\nMore Information<\/a>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n

<\/path><\/svg><\/span>Latest Press Releases<\/span><\/h3>\n\n\n